3 Things You Should Watch For in CVS Health's Q2 Update
A rebuilding year.
That's how CVS Health (NYSE: CVS) CEO Larry Merlo has referenced 2017 in the past. The rebuilding is needed because the large pharmacy services company lost two major contracts in the final four months of 2016 to rival Walgreens Boots Alliance (NASDAQ: WBA).
CVS Health started out 2017 by posting better-than-expected earnings in the first quarter. The company announces its second-quarter results on Aug. 8. Here are three things you should watch for in CVS Health's quarterly update.
Source: Fool.com
CVS Health Corp. Stock
€63.46
1.160%
With 24 Buy predictions and not a single Sell prediction CVS Health Corp. is an absolute favorite of our community.
With a target price of 80 € there is a positive potential of 26.06% for CVS Health Corp. compared to the current price of 63.46 €.
